New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
FDA approves new drug for chronic lymphocytic leukemia, small lymphocytic lymphoma

FDA approves new drug for chronic lymphocytic leukemia, small lymphocytic lymphoma

by Lori SolomonThe U.S. Food and Drug Administration hasapprovedzanubrutinib (Brukinsa), a next-generation BTK inhibitor, for the treatment of patients with chronic lymphocytic leukemia or
World medicine December 16,2023
FDA approves new drug for chronic lymphocytic leukemia, small lymphocytic lymphoma

FDA approves new drug for chronic lymphocytic leukemia, small lymphocytic lymphoma

by Lori SolomonThe U.S. Food and Drug Administration hasapprovedzanubrutinib (Brukinsa), a next-generation BTK inhibitor, for the treatment of patients with chronic lymphocytic leukemia or
World medicine December 16,2023
Starting colonoscopy every 10 years at age 45 cost-effective for all

Starting colonoscopy every 10 years at age 45 cost-effective for all

Initiating colonoscopy every 10 years (Colo10) at age 45 years or an annual fecal immunochemical test (FIT) at 40 years is cost-effective for all body mass index (BMI) and sex groups, according to a s
World medicine December 16,2023
Starting colonoscopy every 10 years at age 45 cost-effective for all

Starting colonoscopy every 10 years at age 45 cost-effective for all

Initiating colonoscopy every 10 years (Colo10) at age 45 years or an annual fecal immunochemical test (FIT) at 40 years is cost-effective for all body mass index (BMI) and sex groups, according to a s
World medicine December 16,2023
FDA approves gene therapy for tough-to-treat bladder cancer

FDA approves gene therapy for tough-to-treat bladder cancer

by Cara Murez HealthDay ReporterPatients with a high-risk bladder cancer now have a new option to treat it.The U.S. Food and Drug Administration has approved agene therapycalled Adstiladri
World medicine December 16,2023
FDA approves gene therapy for tough-to-treat bladder cancer

FDA approves gene therapy for tough-to-treat bladder cancer

by Cara Murez HealthDay ReporterPatients with a high-risk bladder cancer now have a new option to treat it.The U.S. Food and Drug Administration has approved agene therapycalled Adstiladri
World medicine December 16,2023
Betamethasone could improve outcomes for prostate cancer radiation therapy

Betamethasone could improve outcomes for prostate cancer radiation therapy

by Elizabeth Chapin,University of KentuckyBET induces PCa cell death while increasing non-cancer prostate cell viability through mediation of H2O2production. Cells were treated with 5 µM B
World medicine December 16,2023
Betamethasone could improve outcomes for prostate cancer radiation therapy

Betamethasone could improve outcomes for prostate cancer radiation therapy

by Elizabeth Chapin,University of KentuckyBET induces PCa cell death while increasing non-cancer prostate cell viability through mediation of H2O2production. Cells were treated with 5 µM B
World medicine December 16,2023
FDA approves "glowing tumor" imaging drug to aid lung cancer surgery

FDA approves "glowing tumor" imaging drug to aid lung cancer surgery

byPerelman School of Medicine at the University of PennsylvaniaCredit: Pixabay/CC0 Public DomainThe U.S. Food and Drug Administration (FDA) has approved the targeted imaging agent Cytalux (pafol
World medicine December 16,2023
FDA approves "glowing tumor" imaging drug to aid lung cancer surgery

FDA approves "glowing tumor" imaging drug to aid lung cancer surgery

byPerelman School of Medicine at the University of PennsylvaniaCredit: Pixabay/CC0 Public DomainThe U.S. Food and Drug Administration (FDA) has approved the targeted imaging agent Cytalux (pafol
World medicine December 16,2023
Why do men face a higher risk of most types of cancer than women?

Why do men face a higher risk of most types of cancer than women?

byWileyCredit: Pixabay/CC0 Public DomainRates of most types of cancer are higher in men than in women for reasons that are unclear. Results from a recent study published inCancersugg
World medicine December 16,2023
Why do men face a higher risk of most types of cancer than women?

Why do men face a higher risk of most types of cancer than women?

byWileyCredit: Pixabay/CC0 Public DomainRates of most types of cancer are higher in men than in women for reasons that are unclear. Results from a recent study published inCancersugg
World medicine December 16,2023
Researchers offer solution to help tackle patient backlog in the NHS bowel cancer screening program

Researchers offer solution to help tackle patient backlog in the NHS bowel cancer screening program

byQueen Mary, University of LondonCredit: Pixabay/CC0 Public DomainIn England, 37 people die each day from bowel cancer, but screening using fecal blood testing followed by a colonoscopy can red
World medicine December 16,2023
Researchers offer solution to help tackle patient backlog in the NHS bowel cancer screening program

Researchers offer solution to help tackle patient backlog in the NHS bowel cancer screening program

byQueen Mary, University of LondonCredit: Pixabay/CC0 Public DomainIn England, 37 people die each day from bowel cancer, but screening using fecal blood testing followed by a colonoscopy can red
World medicine December 16,2023
New injectable gel offers promise for tough-to-treat brain tumors

New injectable gel offers promise for tough-to-treat brain tumors

by Nicole Sweeney Etter,University of Wisconsin-MadisonCredit: Unsplash/CC0 Public DomainLike the hardiest weed, glioblastoma almost always springs back—usually within months after a patient&#39
World medicine December 16,2023
New injectable gel offers promise for tough-to-treat brain tumors

New injectable gel offers promise for tough-to-treat brain tumors

by Nicole Sweeney Etter,University of Wisconsin-MadisonCredit: Unsplash/CC0 Public DomainLike the hardiest weed, glioblastoma almost always springs back—usually within months after a patient&#39
World medicine December 16,2023
FDA expands indication for use of abemaciclib with early, high-risk breast cancer

FDA expands indication for use of abemaciclib with early, high-risk breast cancer

by Lori SolomonAbemaciclib (Verzenio) with endocrine therapy (tamoxifen or an aromatase inhibitor) is now approved for the adjuvant treatment of adult patients with hormone receptor-positive, human ep
World medicine December 16,2023
FDA expands indication for use of abemaciclib with early, high-risk breast cancer

FDA expands indication for use of abemaciclib with early, high-risk breast cancer

by Lori SolomonAbemaciclib (Verzenio) with endocrine therapy (tamoxifen or an aromatase inhibitor) is now approved for the adjuvant treatment of adult patients with hormone receptor-positive, human ep
World medicine December 16,2023
Researchers decipher a new, unconventional functional mechanism in leukemia cells

Researchers decipher a new, unconventional functional mechanism in leukemia cells

by Peggy Darius,Leipzig UniversityGraphical abstract. Credit:Cancer Research(2022). DOI: 10.1158/0008-5472.can-21-1908Although there has been significant progress in the treatment of
World medicine December 16,2023
Researchers decipher a new, unconventional functional mechanism in leukemia cells

Researchers decipher a new, unconventional functional mechanism in leukemia cells

by Peggy Darius,Leipzig UniversityGraphical abstract. Credit:Cancer Research(2022). DOI: 10.1158/0008-5472.can-21-1908Although there has been significant progress in the treatment of
World medicine December 16,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com